Skip to content

Clinical trials

Expanded access Neuroblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Expanded access Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Available5
No longer available5
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital Medical Center, Cincinnati1
GE Healthcare1
Giselle Sholler1
John Maris1
Jubilant DraxImage Inc.1
Kieuhoa Vo1
Memorial Sloan Kettering Cancer Center1
Northwell Health1
ProgenaBiome1
South Plains Oncology Consortium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma11
Pheochromocytoma4
Medulloblastoma2
Neuroectodermal Tumors, Primitive2
Paraganglioma2
Recurrence2
Dysbiosis1
Hepatoblastoma1
Meningeal Neoplasms1
Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.